Evidence for Synergistic Activity of ELQ-331 or ELQ-468 Plus Atovaquone Against Babesia duncani In Vitro
| Drug Combination . | ΣFIC50 . | Type of Interaction . |
|---|---|---|
| ELQ-331 + atovaquone | 0.6 | Synergistic |
| ELQ-468 + atovaquone | 0.8 | Synergistic |
| Drug Combination . | ΣFIC50 . | Type of Interaction . |
|---|---|---|
| ELQ-331 + atovaquone | 0.6 | Synergistic |
| ELQ-468 + atovaquone | 0.8 | Synergistic |
Abbreviation: ∑FIC50, mean fractional inhibitory concentration.
Evidence for Synergistic Activity of ELQ-331 or ELQ-468 Plus Atovaquone Against Babesia duncani In Vitro
| Drug Combination . | ΣFIC50 . | Type of Interaction . |
|---|---|---|
| ELQ-331 + atovaquone | 0.6 | Synergistic |
| ELQ-468 + atovaquone | 0.8 | Synergistic |
| Drug Combination . | ΣFIC50 . | Type of Interaction . |
|---|---|---|
| ELQ-331 + atovaquone | 0.6 | Synergistic |
| ELQ-468 + atovaquone | 0.8 | Synergistic |
Abbreviation: ∑FIC50, mean fractional inhibitory concentration.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
